Results 171 to 180 of about 4,177,143 (225)

The drug lag and associated factors for orphan anticancer drugs in Japan compared to the United States

Investigational new drugs, 2018
Hiroki Nakayama, Naoki Matsumaru, K. Tsukamoto   +2 more
semanticscholar   +1 more source

Cancer epigenetics in clinical practice

Ca-A Cancer Journal for Clinicians, 2023
Veronica Davalos, Manel Esteller
exaly  

Utilization of the Bridging Strategy for the Development of New Drugs in Oncology to Avoid Drug Lag

Journal of clinical pharmacology, 2017
Seiji Kogure, N. Koyama, S. Hidaka
semanticscholar   +1 more source

Different Development Strategies Affecting Japan’s Drug lag between Japan-Based and Foreign-Based Companies

Therapeutic Innovation and Regulatory Science
Masayasu Hidaka, Hideki Hanaoka, Yoshiaki Uyama   +2 more
semanticscholar   +1 more source

Drug Lag or No Drug Lag?

Science News, 1980
openaire   +1 more source

Legislation, regulation, drug lag, and new drugs.

JAMA, 1979
openaire   +3 more sources

Treatment of muscle‐invasive and advanced bladder cancer in 2020

Ca-A Cancer Journal for Clinicians, 2020
Vaibhav G Patel, William K Oh, Matthew D Galsky   +2 more
exaly  

Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer

Ca-A Cancer Journal for Clinicians, 2023
Laura A Huppert, Hope S Rugo
exaly  

“Drug Lag”

New England Journal of Medicine, 1975
openaire   +1 more source

Comparative Assessment of Drug Lag for Approved Oncology Targeted Therapies Between Saudi Arabia, the United States, and the European Union

Therapeutic Innovation and Regulatory Science
Mohammed A Alnuhait, Abdullah Alshammari, Manar Alharbi, Lina Alotaibi, Reem Alharbi, A. Khobrani, Nora A. Alkhudair, Majed A Alshamrani, Abdullah M. Alrajhi   +8 more
semanticscholar   +1 more source